Aptagen, LLC
RNA
HIV-1 Nuceocapsid
Protein
2.3 nM (reported value)
Binding Buffer (50 mM Tris, pH 7.5, 100 mM NaCl, 1 mM MgCl2, 30 µM ZnCl and 10 mM DTT) SSC buffer (17.5 mM sodium citrate (pH 7.0), 150 mM sodium chloride)
N/A°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
HIV-1 Nuceocapsid (ID# 132)
5'rGprGprAprGprAprCprAprUprCprCprCprUprCprUprUprGprUprUprGprGprUprGprGprUprGprCprCprGprUprGprUprGprGprAprUprGprUprCprUprCp3'
40
12814.65 g/mole
381200 L/(mole·cm)
57.50%
2.62
33.62
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Berglund, A., et al. "A High Affinity Binding Site for the HIV-1 Nucleocapsid Protein." Nucleic Acids Research, 25(1997):1042-1049.
Have your aptamer oligo synthesized ORDER NOW
We are always looking for ways to improve. Please tell us what you think.